A Randomized, Open Label, Comparative Study to Evaluate Effect of Pitavastatin for Reduction of Myocardial Damage in Patient Are Scheduled Elective PCI for Stable Angina Pectoris.

Trial Profile

A Randomized, Open Label, Comparative Study to Evaluate Effect of Pitavastatin for Reduction of Myocardial Damage in Patient Are Scheduled Elective PCI for Stable Angina Pectoris.

Withdrawn prior to enrolment
Phase of Trial: Phase IV

Latest Information Update: 29 Mar 2012

At a glance

  • Drugs Pitavastatin (Primary)
  • Indications Angina pectoris
  • Focus Pharmacodynamics
  • Acronyms PIPA
  • Sponsors JW Pharmaceutical
  • Most Recent Events

    • 29 Mar 2012 Planned end date changed from 1 Aug 2009 to 1 Jul 2010 as reported by ClinicalTrials.gov record.
    • 29 Mar 2012 Status changed from recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov record.
    • 09 Dec 2008 Acronym identified as PIPA as reported by ClinicalTrials.gov
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top